Global RNA Analysis Transcriptomics Market Research Report 2023

Publication ID:

PB503238254

Publication Date:

March 3, 2023

Pages:

103

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Transcriptomics is听the analysis of the RNA transcripts produced by the genotype at a given time that provides a link between the genome, the proteome, and the cellular phenotype. It is a global approach, which together with genomics, proteomics, and metabolomics has evolved in recent years.
Highlights
The global RNA Analysis Transcriptomics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for RNA Analysis Transcriptomics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for RNA Analysis Transcriptomics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for RNA Analysis Transcriptomics in Academic & Research Institutes is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of RNA Analysis Transcriptomics include Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, Agilent Technologies, Illumina, QIAGEN N.V., F. Hoffmann-La Roche, Danaher Corporation and Fluidigm Corporation, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for RNA Analysis Transcriptomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Analysis Transcriptomics.
The RNA Analysis Transcriptomics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global RNA Analysis Transcriptomics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Analysis Transcriptomics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
Bio-Rad Laboratories
Merck KGaA
Agilent Technologies
Illumina
QIAGEN N.V.
F. Hoffmann-La Roche
Danaher Corporation
Fluidigm Corporation
Eurofins Scientific
Sequentia Biotech
Acobiom
GenXPro
CD Genomics
Promega Corporation
Lexogen
Cenix BioScience
Segment by Type
Microarrays
Sequencing
Polymerase Chain Reaction (PCR)
RNA Interference
Segment by Application
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Analysis Transcriptomics companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Analysis Transcriptomics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Microarrays
1.2.3 Sequencing
1.2.4 Polymerase Chain Reaction (PCR)
1.2.5 RNA Interference
1.3 Market by Application
1.3.1 Global RNA Analysis Transcriptomics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Academic & Research Institutes
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Hospitals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Analysis Transcriptomics Market Perspective (2018-2029)
2.2 RNA Analysis Transcriptomics Growth Trends by Region
2.2.1 Global RNA Analysis Transcriptomics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 RNA Analysis Transcriptomics Historic Market Size by Region (2018-2023)
2.2.3 RNA Analysis Transcriptomics Forecasted Market Size by Region (2024-2029)
2.3 RNA Analysis Transcriptomics Market Dynamics
2.3.1 RNA Analysis Transcriptomics Industry Trends
2.3.2 RNA Analysis Transcriptomics Market Drivers
2.3.3 RNA Analysis Transcriptomics Market Challenges
2.3.4 RNA Analysis Transcriptomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Analysis Transcriptomics Players by Revenue
3.1.1 Global Top RNA Analysis Transcriptomics Players by Revenue (2018-2023)
3.1.2 Global RNA Analysis Transcriptomics Revenue Market Share by Players (2018-2023)
3.2 Global RNA Analysis Transcriptomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNA Analysis Transcriptomics Revenue
3.4 Global RNA Analysis Transcriptomics Market Concentration Ratio
3.4.1 Global RNA Analysis Transcriptomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Analysis Transcriptomics Revenue in 2022
3.5 RNA Analysis Transcriptomics Key Players Head office and Area Served
3.6 Key Players RNA Analysis Transcriptomics Product Solution and Service
3.7 Date of Enter into RNA Analysis Transcriptomics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Analysis Transcriptomics Breakdown Data by Type
4.1 Global RNA Analysis Transcriptomics Historic Market Size by Type (2018-2023)
4.2 Global RNA Analysis Transcriptomics Forecasted Market Size by Type (2024-2029)
5 RNA Analysis Transcriptomics Breakdown Data by Application
5.1 Global RNA Analysis Transcriptomics Historic Market Size by Application (2018-2023)
5.2 Global RNA Analysis Transcriptomics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America RNA Analysis Transcriptomics Market Size (2018-2029)
6.2 North America RNA Analysis Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America RNA Analysis Transcriptomics Market Size by Country (2018-2023)
6.4 North America RNA Analysis Transcriptomics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Analysis Transcriptomics Market Size (2018-2029)
7.2 Europe RNA Analysis Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe RNA Analysis Transcriptomics Market Size by Country (2018-2023)
7.4 Europe RNA Analysis Transcriptomics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Analysis Transcriptomics Market Size (2018-2029)
8.2 Asia-Pacific RNA Analysis Transcriptomics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific RNA Analysis Transcriptomics Market Size by Region (2018-2023)
8.4 Asia-Pacific RNA Analysis Transcriptomics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Analysis Transcriptomics Market Size (2018-2029)
9.2 Latin America RNA Analysis Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America RNA Analysis Transcriptomics Market Size by Country (2018-2023)
9.4 Latin America RNA Analysis Transcriptomics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Analysis Transcriptomics Market Size (2018-2029)
10.2 Middle East & Africa RNA Analysis Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa RNA Analysis Transcriptomics Market Size by Country (2018-2023)
10.4 Middle East & Africa RNA Analysis Transcriptomics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific RNA Analysis Transcriptomics Introduction
11.1.4 Thermo Fisher Scientific Revenue in RNA Analysis Transcriptomics Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories RNA Analysis Transcriptomics Introduction
11.2.4 Bio-Rad Laboratories Revenue in RNA Analysis Transcriptomics Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA RNA Analysis Transcriptomics Introduction
11.3.4 Merck KGaA Revenue in RNA Analysis Transcriptomics Business (2018-2023)
11.3.5 Merck KGaA Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies RNA Analysis Transcriptomics Introduction
11.4.4 Agilent Technologies Revenue in RNA Analysis Transcriptomics Business (2018-2023)
11.4.5 Agilent Technologies Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina RNA Analysis Transcriptomics Introduction
11.5.4 Illumina Revenue in RNA Analysis Transcriptomics Business (2018-2023)
11.5.5 Illumina Recent Development
11.6 QIAGEN N.V.
11.6.1 QIAGEN N.V. Company Detail
11.6.2 QIAGEN N.V. Business Overview
11.6.3 QIAGEN N.V. RNA Analysis Transcriptomics Introduction
11.6.4 QIAGEN N.V. Revenue in RNA Analysis Transcriptomics Business (2018-2023)
11.6.5 QIAGEN N.V. Recent Development
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Detail
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche RNA Analysis Transcriptomics Introduction
11.7.4 F. Hoffmann-La Roche Revenue in RNA Analysis Transcriptomics Business (2018-2023)
11.7.5 F. Hoffmann-La Roche Recent Development
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Detail
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation RNA Analysis Transcriptomics Introduction
11.8.4 Danaher Corporation Revenue in RNA Analysis Transcriptomics Business (2018-2023)
11.8.5 Danaher Corporation Recent Development
11.9 Fluidigm Corporation
11.9.1 Fluidigm Corporation Company Detail
11.9.2 Fluidigm Corporation Business Overview
11.9.3 Fluidigm Corporation RNA Analysis Transcriptomics Introduction
11.9.4 Fluidigm Corporation Revenue in RNA Analysis Transcriptomics Business (2018-2023)
11.9.5 Fluidigm Corporation Recent Development
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Detail
11.10.2 Eurofins Scientific Business Overview
11.10.3 Eurofins Scientific RNA Analysis Transcriptomics Introduction
11.10.4 Eurofins Scientific Revenue in RNA Analysis Transcriptomics Business (2018-2023)
11.10.5 Eurofins Scientific Recent Development
11.11 Sequentia Biotech
11.11.1 Sequentia Biotech Company Detail
11.11.2 Sequentia Biotech Business Overview
11.11.3 Sequentia Biotech RNA Analysis Transcriptomics Introduction
11.11.4 Sequentia Biotech Revenue in RNA Analysis Transcriptomics Business (2018-2023)
11.11.5 Sequentia Biotech Recent Development
11.12 Acobiom
11.12.1 Acobiom Company Detail
11.12.2 Acobiom Business Overview
11.12.3 Acobiom RNA Analysis Transcriptomics Introduction
11.12.4 Acobiom Revenue in RNA Analysis Transcriptomics Business (2018-2023)
11.12.5 Acobiom Recent Development
11.13 GenXPro
11.13.1 GenXPro Company Detail
11.13.2 GenXPro Business Overview
11.13.3 GenXPro RNA Analysis Transcriptomics Introduction
11.13.4 GenXPro Revenue in RNA Analysis Transcriptomics Business (2018-2023)
11.13.5 GenXPro Recent Development
11.14 CD Genomics
11.14.1 CD Genomics Company Detail
11.14.2 CD Genomics Business Overview
11.14.3 CD Genomics RNA Analysis Transcriptomics Introduction
11.14.4 CD Genomics Revenue in RNA Analysis Transcriptomics Business (2018-2023)
11.14.5 CD Genomics Recent Development
11.15 Promega Corporation
11.15.1 Promega Corporation Company Detail
11.15.2 Promega Corporation Business Overview
11.15.3 Promega Corporation RNA Analysis Transcriptomics Introduction
11.15.4 Promega Corporation Revenue in RNA Analysis Transcriptomics Business (2018-2023)
11.15.5 Promega Corporation Recent Development
11.16 Lexogen
11.16.1 Lexogen Company Detail
11.16.2 Lexogen Business Overview
11.16.3 Lexogen RNA Analysis Transcriptomics Introduction
11.16.4 Lexogen Revenue in RNA Analysis Transcriptomics Business (2018-2023)
11.16.5 Lexogen Recent Development
11.17 Cenix BioScience
11.17.1 Cenix BioScience Company Detail
11.17.2 Cenix BioScience Business Overview
11.17.3 Cenix BioScience RNA Analysis Transcriptomics Introduction
11.17.4 Cenix BioScience Revenue in RNA Analysis Transcriptomics Business (2018-2023)
11.17.5 Cenix BioScience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Thermo Fisher Scientific
Bio-Rad Laboratories
Merck KGaA
Agilent Technologies
Illumina
QIAGEN N.V.
F. Hoffmann-La Roche
Danaher Corporation
Fluidigm Corporation
Eurofins Scientific
Sequentia Biotech
Acobiom
GenXPro
CD Genomics
Promega Corporation
Lexogen
Cenix BioScience

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂